Anzemet and Zide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Anzemet (dolasetron mesylate) and Zide (hydrochlorothiazide). Common drug interactions include bone disorder among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people have when they take Anzemet and Zide. It is created by eHealthMe based on reports of 78 people who take the same drugs from the FDA, and is updated regularly.

What is Anzemet?

Anzemet has active ingredients of dolasetron mesylate. eHealthMe is studying from 2,603 Anzemet users. Check the latest studies of Anzemet.

What is Zide?

Zide has active ingredients of hydrochlorothiazide. It is often used in high blood pressure. eHealthMe is studying from 183,246 Zide users. Check the latest studies of Zide.



On Aug, 05, 2026

78 people who take Anzemet and Zide together, and have interactions are studied.

Anzemet and Zide drug interactions.

What are the common drug interactions of Anzemet and Zide, by gender? *:

female:

  1. Bone disorder
  2. Lymphadenopathy (disease or enlargement of lymph nodes)
  3. Osteolysis (dissolution of bone)
  4. Abscess (pus)
  5. Asthenia (weakness)
  6. Cataract (clouding of the lens inside the eye)
  7. Cough
  8. Diverticulum intestinal (a pouch that is attached to the first part of the small intestine)
  9. Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)
  10. Intervertebral disc protrusion (spinal disc protrusion)

male:

  1. Diarrhoea
  2. Blood sodium decreased
  3. Renal failure (kidney dysfunction)
  4. Vomiting
  5. Blood glucose increased
  6. Blood potassium decreased
  7. Dehydration (dryness resulting from the removal of water)
  8. Fatigue (feeling of tiredness)
  9. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  10. Haematocrit decreased

What are the common drug interactions of Anzemet and Zide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Abscess (pus)
  2. Aphasia (damage to the parts of the brain that control language)
  3. Arthralgia (joint pain)
  4. Arthropathy
  5. Back pain
  6. Blood cholesterol increased
  7. Bone disorder
  8. Breast cyst
  9. Breast mass
  10. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)

30-39:

n/a

40-49:

  1. Anxiety
  2. Bone lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries)
  3. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  4. Diverticulum intestinal (a pouch that is attached to the first part of the small intestine)
  5. Intervertebral disc protrusion (spinal disc protrusion)
  6. Oedema peripheral (superficial swelling)
  7. Osteonecrosis of jaw (death of bone of jaw)
  8. Pain
  9. Pathological fracture (broken bone caused by disease)
  10. Spinal osteoarthritis (joint cartilage loss in spine)

50-59:

  1. Arthralgia (joint pain)
  2. Bone disorder
  3. Nausea (feeling of having an urge to vomit)
  4. Osteopenia (a condition where bone mineral density is lower than normal)
  5. Swelling
  6. Tooth extraction
  7. Vomiting
  8. Fatigue (feeling of tiredness)
  9. Lymphadenopathy (disease or enlargement of lymph nodes)
  10. Neutropenia (an abnormally low number of neutrophils)

60+:

  1. Diarrhoea
  2. Pyrexia (fever)
  3. Pain
  4. Urinary tract infection
  5. Abscess jaw (tooth abscess or root abscess)
  6. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  7. Angina pectoris (chest pain due to ischemia of the heart muscle)
  8. Anxiety
  9. Aortic arteriosclerosis (hardening of the aortic arteries)
  10. Bladder cancer recurrent

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 13 people, 16.67%
  2. Lung Cancer - Non-Small Cell (lung cancer): 7 people, 8.97%
  3. Resorption Bone Increased: 6 people, 7.69%
  4. Pain: 5 people, 6.41%
  5. Sleep Disorder: 4 people, 5.13%
  6. Hypercalcaemia (elevated calcium (ca+) level in the blood): 4 people, 5.13%
  7. Breast Cancer Female: 4 people, 5.13%
  8. Breast Cancer: 4 people, 5.13%
  9. Bone Density Decreased: 4 people, 5.13%

* Approximation only. Some reports may have incomplete information.

Do you take Anzemet and Zide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Anzemet and Zide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Anzemet:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Zide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Anzemet and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on dolasetron mesylate and hydrochlorothiazide (the active ingredients of Anzemet and Zide, respectively), and Anzemet and Zide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: